News.

AI tool addressing questions on Göttingen Minipigs

The Ellegaard Göttingen Minipigs A/S has developed an AI Chatbot, where you can ask questions concerning Göttingen Minipigs. The new AI tool answers your questions about Göttingen Minipigs in biomedical research based on existing research published on PubMed and...

read more

Project fact sheets published

The NHPig project fact sheets are now available on the European Commission and IHI websites. Click on the images below to read the official announcements and stay informed about our latest research.  

read more
Successful Kick-Off for the NHPig Project in Freising

Successful Kick-Off for the NHPig Project in Freising

We are excited to announce the successful kick-off of our NHPig project held on November 18-19, 2024, in Freising, Germany. This innovative project aims to expand translational knowledge in minipigs, paving the way to reduce and replace non-human primates in...

read more
NHPig EU Project Launches to Transform Non-Clinical Research

NHPig EU Project Launches to Transform Non-Clinical Research

München, 22 November 2024 Our consortium today announced the launch of NHPig, an EU-funded research project aimed at transforming non-clinical safety assessment by use of mini- and micropig models. The goal is to expand and share biological knowledge on mini- and...

read more

Funding acknowledgement

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101165643. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Vaccines Europe, EuropaBio and MedTech Europe and Breakthrough T1D and VeriSIM Life.

Funding acknowledgement

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101165643. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Vaccines Europe, EuropaBio and MedTech Europe and Breakthrough T1D and VeriSIM Life.